GlassScriptPhysician profile
Ralph Jr Austin
NPI 1093758294
$1,947.76
in general payments reported to CMS, 2019-2025
22 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $498 · 2022: $259 · 2023: $759 · 2024: $260 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $512.87 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astellas Pharma US INC | $444.32 | 2021-2025 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $284.77 | 2021-2023 | Trelegy Ellipta, Shingrix |
| Sanofi-Aventis U.S. LLC | $124.41 | 2023 | |
| Abbott Laboratories | $59.52 | 2021-2024 | Freestyle Libre |
| Novartis Pharmaceuticals Corporation | $59.26 | 2023 | |
| Amgen INC. | $58.97 | 2023 | Repatha |
| Shield Therapeutics INC | $40.91 | 2023 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $37.17 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.04 | 2023-2024 | Jardiance, Synjardy, Tradjenta |
| Astrazeneca Pharmaceuticals LP | $35.52 | 2023-2024 | Farxiga |
| Esperion Therapeutics, INC. | $33.15 | 2021-2022 | |
| Dexcom, INC. | $31.74 | 2021 | |
| Pfizer INC. | $28.64 | 2021-2023 | |
| Genzyme Corporation | $24.35 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $23.59 | 2023 | Spravato |
| Xeris Pharmaceuticals, INC. | $21.70 | 2021 | |
| Sanofi Pasteur INC. | $20.73 | 2023 | |
| Amarin Pharma, INC. | $20.32 | 2022 | |
| Nestle Healthcare Nutrition INC. | $19.84 | 2021 | |
| Lilly USA, LLC | $15.23 | 2022 | |
| Echosens North America, INC. | $14.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.